mitiglinide has been researched along with diazoxide in 2 studies
| Studies (mitiglinide) | Trials (mitiglinide) | Recent Studies (post-2010) (mitiglinide) | Studies (diazoxide) | Trials (diazoxide) | Recent Studies (post-2010) (diazoxide) |
|---|---|---|---|---|---|
| 120 | 30 | 50 | 2,923 | 86 | 445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Aizawa, T; Katsuno, K; Kobayashi, M; Koizumi, T; Ohnota, H; Sato, F | 1 |
2 other study(ies) available for mitiglinide and diazoxide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro insulinotropic action of a new non-sulfonylurea hypoglycemic agent, calcium (2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate dihydrate (KAD-1229), in rat pancreatic B-cells.
Topics: Animals; Diazoxide; Hypoglycemic Agents; In Vitro Techniques; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Isoindoles; Male; Norepinephrine; Pancreas; Rats; Rats, Sprague-Dawley; Sulfonylurea Compounds | 1995 |